Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1

GLIA

Volumn 57, Issue 16, 2009, Pages 1815-1824

  Edgar, Julia M ^a   McLaughlin, Mark ^a   Werner, Hauke B ^b   McCulloch, Mailis C ^a   Barrie, Jennifer A ^a   Brown, Angus ^c   Faichney, Andrew Blyth ^a   Snaidero, Nicolas ^a,b   Nave, Klaus Armin ^b   Griffiths, Ian R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Inner tongue; Morphometric analysis; Myelin; Oligodendrocyte; Proteolipid protein

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; MYELIN; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL JUNCTION; CELL SIZE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; MALE; MORPHOMETRICS; MOUSE; MYELINATION; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE POTENTIAL; NEWBORN; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; AXONS; CELL SURVIVAL; ELECTROPHYSIOLOGY; INTERCELLULAR JUNCTIONS; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; OPTIC NERVE; SPINAL CORD;

EID: 71249109336     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20893     Document Type: Article

References (44)

1. Allen L, Anderson S, Wender R, Meakin P, Ransom BR, Ray DE, Brown AM. 2006. Fructose supports energy metabolism of some, but not all, axons in adult mouse optic nerve. J Neurophysiol 95:1917-1925.
2. Bifulco M, Laezza C, Stingo S, Wolff J. 2002. 2′,3′-Cyclic nucleotide 3′- phosphodiesterase: A membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci USA 99: 1807-1812. (Pubitemid 34168971)
3. Braun PE, Gravel M. 2004. 2′,3′-cyclic nucleotide-3′- phosphodiesterase: Structure, Biology, and Function. In: Lazzarini A, Griffin JW, Lassmann H, Nave KA, Miller RH, Trapp BD, editors. Myelin biology and disorders. Elsevier: Amsterdam. pp 499-522.
4. Brown AM. 2006. A non-linear regression analysis program for describing electrophysiological data with multiple functions using Microsoft Excel. Comput Methods Programs Biomed 82:51-57.
5. Coleman M. 2005. Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 6:889-898. (Pubitemid 41568730)
6. De Angelis D, Cox M, Gao E, Braun PE. 1994. Cellular and molecular characteristics of CNP suggest regulatory mechanisms in myelinogenesis. In: Salvati S, editor. A multidiscipinary approach to myelin diseases II. New York: Plenum Press. pp 49-58.
7. De Angelis DA, Braun PE. 1994. Isoprenylation of brain 2′,3′-cyclic nucleotide 3′-phosphodiesterase modulates cell morphology. J Neurosci Res 39:386-397.
8. De Angelis DA, Braun PE. 1996. 2′,3′-cyclic nucleotide 3′-phosphodiesterase binds to actin-based cytoskeletal elements in an isoprenylation- independent manner. J Neurochem 67:943-951.
9. DeLuca GC, Ebers GC, Esiri MM. 2004. The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30:576-584.
10. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler J, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave K-A, Griffiths IR. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166: 121-131. (Pubitemid 38931922)
11. Esposito C, Scrima M, Carotenuto A, Tedeschi A, Rovero P, D'Errico G, Malfitano AM, Bifulco M, D'Ursi AM. 2008. Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2′,3′-cyclic nucleotide-3′-phosphodiesterase. Biochemistry 47:308-319.
12. Evangelou N, Konz D, Esiri MM, Smith M, Palace J, Matthews PM. 2001. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124:1813-1820. (Pubitemid 32845442)
13. Friede RL, Bischhausen R. 1978. How do axons control myelin formation? The model of 6-aminonicotinamide neuropathy. J Neurol Sci 35: 341-353. (Pubitemid 8282570)
14. Ganter P, Prince C, Esiri MM. 1999. Spinal cord axonal loss in multiple sclerosis: A post-mortem study. Neuropathol Appl Neurobiol 25:459-467. (Pubitemid 30045420)
15. Garbern J, Yool DA, Moore GJ, Wilds I, Faulk M, Klugmann M, Nave K-A, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz J, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
16. Gravel M, Peterson J, Yong VW, Kottis V, Trapp B, Braun PE. 1996. Overexpression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci 7:453-466. (Pubitemid 26300332)
17. Gravel M, Robert F, Kottis V, Gallouzi IE, Pelletier J, Braun PE. 2009. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: A novel RNA-binding protein that inhibits protein synthesis. J Neurosci Res 87:1069-1079.
18. Griffiths IR, Duncan ID, McCulloch M. 1981. Shaking pup: A disorder of central myelination in the spaniel dog. II. Ultrastructural observations on the white matter of cervical spinal cord J Neurocytol 10: 847-858.
19. Griffiths IR, Klugmann M, Anderson TJ, Yool D, Thomson CE, Schwab MH, Schneider A, Zimmermann F, McCulloch MC, Nadon NL, Nave K-A. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613. (Pubitemid 28278256)
20. Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, Werner HB, Natt O, Michaelis T, Prinz M, Frahm J, Nave KA. 2007. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39:969-976. (Pubitemid 47185174)
21. Kikuchi T, Mukoyama M, Yamazaki K, Moriya H. 1990. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse. Acta Neuropathol (Berl) 80:145-151. (Pubitemid 20196804)
22. Kimura M, Inoko H, Katsuki M, Ando A, Sato T, Hirose T, Takashima H, Inayama S, Okano H, Takamatsu K. 1985. Molecular genetic analysis of myelin-deficient mice: Shiverer mutant mice show deletion in gene(s) coding for myelin basic protein. J Neurochem 44:692-696. (Pubitemid 15108822)
23. Klugmann M, Schwab MH, Pühlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave K-A. 1997. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70. (Pubitemid 27053830)
24. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave K-A. 2003. Disruption of the CNP gene uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374. (Pubitemid 36278853)
25. Lee J, Gravel M, Zhang R, Thibault P, Braun PE. 2005. Process out-growth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol 170:661-673. (Pubitemid 41186940)
26. Meakin PJ, Fowler MJ, Rathbone AJ, Allen LM, Ransom BR, Ray DE, Brown AM. 2007. Fructose metabolism in the adult mouse optic nerve, a central white matter tract. J Cereb Blood Flow Metab 27:86-99.
27. Mi WQ, Conforti L, Coleman MP. 2002. Genotyping methods to detect a unique neuroprotective factor (Wlds) for axons. J Neurosci Methods 113:215-218. (Pubitemid 34076544)
28. Nave KA, Trapp BD. 2008. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31:535-561.
29. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL. 2005. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS, PNS: Neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol 195:208-217. (Pubitemid 41116825)
30. Ransom BR, Butt AM, Black JA. 1991. Ultrastructural identification of HRP-injected oligodendrocytes in the intact rat optic nerve. Glia 4: 37-45.
31. Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, Nave K-A, Bansal R. 2005. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50:86-90. (Pubitemid 40516823)
32. Simons M, Krämer EM, Thiele C, Stoffel W, Trotter J. 2000. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 151:143-153. (Pubitemid 30761127)
33. Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, Ordinario AT, Bruck W, Lassmann H. 2005. Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis. Brain 128:979-987. (Pubitemid 40675454)
34. Stys PK, Ransom BR, Waxman SG. 1991. Compound action potential of nerve recorded by suction electrode: A theoretical and experimental analysis. Brain Res 546:18-32.
35. Terao S, Sobue G, Hashizume Y, Shimada N, Mitsuma T. 1994. Age-related changes of the myelinated fibers in the human corticospinal tract: A quantitative analysis. Acta Neuropath (Berl) 88:137-142. (Pubitemid 24233244)
36. Thurnherr T, Benninger Y, Wu X, Chrostek A, Krause SM, Nave KA, Franklin RJ, Brakebusch C, Suter U, Relvas JB. 2006. Cdc42 and Rac1 signaling are both required for and act synergistically in the correct formation of myelin sheaths in the CNS. J Neurosci 26: 10110-10119. (Pubitemid 44527405)
37. Trapp BD, Bernier L, Andrews B, Colman DR. 1988. Cellular and sub-cellular distribution of 2′,3′-cyclic nucleotide 3′-phosphodiesterase and its mRNA in the rat central nervous system. J Neurochem 51: 859-868. (Pubitemid 18205776)
38. Trapp BD, Nave KA. 2008. Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269.
39. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG, Mobius W, Guarente L, Casaccia-Bonnefil P, Jahn O, Nave K-A. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27: 7717-7730. (Pubitemid 47093807)
40. Williams MA. 1977. Stereological techniques. In: Glauert AM, editor. Practical methods in electron microscopy, Vol.6: Quantitative methods in biology. Amsterdam: North Holland. pp 5-84.
41. Witt A, Brady ST. 2000. Unwrapping new layers of complexity in axon/- glial relationships. Glia 29:112-117. (Pubitemid 30044504)
42. Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, Nave KA, Macklin WB, Trapp BD. 2006. Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol 172:469-478. (Pubitemid 43187942)
43. Yin X, Peterson J, Gravel M, Braun PE, Trapp BD. 1997. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. J Neurosci Res 50:238-247. (Pubitemid 27473639)
44. Yin XH, Crawford TO, Griffin JW, Tu PH, Lee VM, Li CM, Roder J, Trapp BD. 1998. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953-1962. (Pubitemid 28141401)